SCHEMBL3111136

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3107512	0.89	RBP4 (0.53)	RBP4NPC1RAB9ASMN1; SMN2MRGPRX4
	SCHEMBL3113192	0.89	RBP4 (0.67)	RBP4NPSR1RXRARXRBRXRG
	SCHEMBL3094503	0.84	RBP4 (0.69)	RBP4HPGD
	SCHEMBL3106015	0.82	RBP4 (0.59)	RBP4LMNA
	SCHEMBL3113965	0.82	RBP4 (0.58)	RBP4
	SCHEMBL3094577	0.81	RBP4 (0.78)	RBP4NPC1SMN1; SMN2POLBHPGD
	SCHEMBL3108139	0.78	RBP4 (0.65)	RBP4RXRARXRBRXRGHPGD
	SCHEMBL3104804	0.78	RBP4 (1.00)	RBP4NPSR1RXRARXRBRXRG
	SCHEMBL18404037	0.78	RBP4 (0.58)	RBP4NPSR1RXRARXRBRXRG
	SCHEMBL3104734	0.78	RBP4 (0.53)	RBP4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.